Vascular and cardiovascular diseases

Cardiovascular diseases (CVDs) underlie the core of IPST’s service portfolio. Our robust, predictive animal models of arrhythmia and left or right ventricular failure have successfully supported marketed drugs since 1999.

Discover our most popular White papers for this area of expertise

Read it here

A strategy to develop a cardiac anti-arrhythmic drug from scratch

by Dany Salvail Ph.D., Vice-President.

Published on June 19, 2023

Read more

Translation

by Dany Salvail Ph.D., Vice-President.

Published on May 9, 2023

Read more
01 / Cardiovascular

Cardiovascular diseases

We leverage our world-class expertise on cardiovascular diseases, e.g., pulmonary arterial hypertension, myocardial infarction, hemorrhagic shock, acute kidney injury, to craft tailored protocols designed in collaboration with you.
Read More
02 / Inflammatory

Inflammatory disorders

We leverage our world-class expertise on inflammatory disorders, e.g., diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibrosis, cholestatic liver disease, to craft tailored protocols designed in collaboration with you.
Read More
03 / Respiratory

Respiratory diseases

We leverage our world-class expertise on respiratory diseases e.,g., chronic obstructive pulmonary disease, asthma, allergic rhinitis, pulmonary fibrosis, to craft tailored protocols designed in collaboration with you.
Read More
04 / Bleeding

Bleeding disorders

We leverage our world-class expertise on bleeding disorders, e.g., hemophilia, sickle cell anemia, immune thrombocytopenia, von Willebrand disease, to craft tailored protocols designed in collaboration with you.
Read More